Compound 1050
Identifiers
- Canonical SMILES:
CN1CCN(CC1)C(=O)c1ccc(cc1)-n1[nH]c2c3cnn(C)c3nc(-c3cccc(c3)C(F)(F)F)c2c1=O
- InChi:
InChI=1S/C27H24F3N7O2/c1-34-10-12-36(13-11-34)25(38)16-6-8-19(9-7-16)37-26(39)21-22(17-4-3-5-18(14-17)27(28,29)30)32-24-20(23(21)33-37)15-31-35(24)2/h3-9,14-15,33H,10-13H2,1-2H3
- InChiKey:
HVINNIVOFPHNKC-UHFFFAOYSA-N
External links
168318100 |
External search
Bibliography (1)
Pharmacological data
Biochemical tests | Cellular tests | PK tests | Cytotoxicity tests |
---|---|---|---|
1 | 0 | 0 | 0 |
Targets
PPI family | Best activity | Diseases | MMoA |
---|---|---|---|
CD80 / CD28 | 6.30 | cancer | Inhibition |
Physicochemical filters
Descriptor | Lipinski's RO5 | Veber | Pfizer's 3/75 | |
---|---|---|---|---|
Compliance | ||||
MW | 535.19 g/mol | |||
HBA | 9 | |||
HBD | 1 | |||
HBA + HBD | 10 | |||
AlogP | 4.14 | |||
TPSA | 86.60 | |||
RB | 4 |
Radar chart
PCA : iPPI-DB chemical space
PCA : Correlation circle
Efficiencies: iPPI-DB biplot LE versus LLE
Summary
Bibliographic ressources | Biochemical tests | Cellular tests | PK tests | Cytotoxicity tests |
---|---|---|---|---|
1 | 1 | 0 | 0 | 0 |
Ta | Structure | Name | Drugbank ID |
---|---|---|---|
0.4837 | N-cyclopropyl-3-{[1-(2,4-difluorophenyl)-7-methyl-6-oxo-6,7-dihydro-1H-pyrazolo[3,4-b]pyridin-4-yl]amino}-4-methylbenzamide | DB08349 | |
0.4751 | Risdiplam | DB15305 | |
0.4718 | Riociguat | DB08931 | |
0.4712 | 6-CHLORO-9-HYDROXY-1,3-DIMETHYL-1,9-DIHYDRO-4H-PYRAZOLO[3,4-B]QUINOLIN-4-ONE | DB07218 | |
0.4638 | ATX-914 | DB12673 | |
0.4628 | Vericiguat | DB15456 | |
0.4541 | ABT-288 | DB15192 | |
0.4538 | Merestinib | DB12381 | |
0.4530 | Decoglurant | DB11923 | |
0.4523 | Dilmapimod | DB12140 | |
0.4504 | MK-0249 | DB11910 | |
0.4487 | Ispinesib | DB06188 | |
0.4444 | Tepotinib | DB15133 | |
0.4418 | CCX-354 | DB12963 | |
0.4386 | 5-(2-fluorophenyl)-N-(pyridin-4-ylmethyl)pyrazolo[1,5-a]pyrimidin-7-amine | DB08534 |